Genome-wide association study for circulating levels of soluble receptor for advanced glycation end-products (sRAGE)

被引：0
|
作者：
Deshmukh, H. [1 ]
McKeigue, P. M. [2 ]
Looker, H. C. [1 ]
Van Zuydam, N. [3 ]
Ahlqvist, E. [4 ]
Hitman, G. A. [5 ]
Palmer, C. N. A. [1 ]
Colhoun, H. M. [1 ]
机构：
[1] Univ Dundee, Dundee DD1 4HN, Scotland
[2] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland
[3] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England
[4] Lund Univ, Malmo, Sweden
[5] Barts & London, Blizard Inst, London, England
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
173
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [21] Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?
    Lorenzi, Rodrigo
    Grossin, Nicolas
    Lambert, Marc
    Daroux, Maite
    Adjoutah, Zoubir
    Flahaut, Christophe
    Jacolot, Philippe
    Tessier, Frederic J.
    Lefranc, Didier
    Desremaux, Pierre
    Dubucquoi, Sylvain
    Boulanger, Eric
    ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (02) : 248 - 257
  • [22] Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years
    Magnier, Julie
    Julian, Valerie
    Sapin, Vincent
    Mulliez, Aurelien
    Usclade, Alexandra
    Rochette, Emmanuelle
    Evrard, Bertrand
    Labbe, Andre
    Coste, Karen
    Egron, Carole
    APPLIED SCIENCES-BASEL, 2022, 12 (12):
  • [23] Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure
    Basta, Giuseppina
    Del Turco, Serena
    Navarra, Teresa
    Lee, William M.
    LIVER TRANSPLANTATION, 2015, 21 (06) : 847 - 854
  • [24] Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: The Northern Manhattan Study
    Hudson, Barry I.
    Dong, Chuanhui
    Gardener, Hannah
    Elkind, Mitchell S. V.
    Wright, Clinton B.
    Goldberg, Ron
    Sacco, Ralph L.
    Rundek, Tatjana
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (09): : 1125 - 1130
  • [25] Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)
    Hanford, LE
    Enghild, JJ
    Valnickova, Z
    Petersen, SV
    Schaefer, LM
    Schaefer, TM
    Reinhart, TA
    Oury, TD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) : 50019 - 50024
  • [26] Association of Soluble Receptor for Advanced Glycation End Products Levels with Hypertensive Albuminuria
    Zheng, Huan
    Yuan, Lingyan
    Xie, Nanzi
    Xu, Huifeng
    Xie, Xiaoyun
    Luo, Ming
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (02) : 259 - 264
  • [27] Purification and Characterization of the Soluble form of the Receptor for Advanced Glycation End-Products (sRAGE): A Novel Fast, Economical and Convenient Method
    Kumar, Varun
    Sulaj, Alba
    Fleming, Thomas
    Nawroth, Peter P.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2018, 126 (03) : 141 - 147
  • [28] Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer
    Krechler, Tomas
    Jachymova, Marie
    Mestek, Oto
    Zak, Ales
    Zima, Tomas
    Kalousova, Marta
    CLINICAL BIOCHEMISTRY, 2010, 43 (10-11) : 882 - 886
  • [29] SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (SRAGE) IN TYPE 2 DIABETIC PATIENTS: RELATION TO INSULIN RESISTANCE AND ATHEROGENESIS
    Kravchun, N.
    Gorshunska, M.
    Krasova, N.
    Karachentsev, I.
    Jansen, E.
    Poltorak, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [30] Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study
    Laudenslager, Marci
    Lazo, Mariana
    Wang, Dan
    Selvin, Elizabeth
    Chen, Po-Hung
    Pankow, James S.
    Clark, Jeanne M.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (07) : 873 - 878
12345